The Recall Desk

Category

Drug recalls

FDA recalls of prescription and over-the-counter drugs.

About drug recalls

FDA drug recalls cover prescription medicines, over-the-counter products, biologic and gene therapies, and active pharmaceutical ingredients (the raw drug substances that manufacturers compound into finished products). Recall classifications follow the same Class I / II / III system as food, and most published recalls are Class II — the product is unlikely to cause permanent harm but doesn't meet specification.

The most common reasons for a drug recall are out-of-specification potency or dissolution (the active ingredient is present in too high or too low a dose), microbial contamination, particulate matter in injectables, mix-ups during packaging where bottles end up with the wrong tablets, and nitrosamine impurities in certain drug classes. Many drug recalls are at the lot level — the manufacturer's whole product line is still safe to use, but specific production lots are pulled.

If a recall affects your medication: don't stop taking it on your own. Call your prescriber or pharmacist before doing anything. Stopping a prescribed drug abruptly can be more dangerous than the issue prompting the recall. Most drug-recall remedies route through the dispensing pharmacy, who'll either swap your supply for an unaffected lot or coordinate a refund with the manufacturer.

126–150 of 5113

  • HighFDA (Drugs)·D-0584-2026·2026-06-10

    [pending] NIACIN (NIACIN)

    Pending LLM rewrite. Source: FDA_DRUG D-0584-2026.

    Product
    NIACIN — NIACIN (NIACIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0555-2026·2026-06-10

    [pending] DULOXETINE (DULOXETINE)

    Pending LLM rewrite. Source: FDA_DRUG D-0555-2026.

    Product
    DULOXETINE — DULOXETINE (DULOXETINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0550-2026·2026-06-03

    [pending] NICOTINE (NICOTINE)

    Pending LLM rewrite. Source: FDA_DRUG D-0550-2026.

    Product
    NICOTINE — NICOTINE (NICOTINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0551-2026·2026-06-03

    [pending] PRED MILD (PREDNISOLONE ACETATE)

    Pending LLM rewrite. Source: FDA_DRUG D-0551-2026.

    Product
    PRED MILD — PRED MILD (PREDNISOLONE ACETATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0538-2026·2026-05-27

    Atomoxetine Capsules Recalled Due to Labeling Mix-Up Error

    Safecor Health, LLC is recalling Atomoxetine HCl 10 mg capsules because some units are incorrectly labeled as 10 mg when they actually contain 25 mg. Patients taking the mislabeled product may receive an incorrect dose.

    Product
    ATOMOXETINE — ATOMOXETINE (ATOMOXETINE)
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0544-2026·2026-05-27

    Erythromycin Tablets Recalled for Impurity Above Acceptable Limits

    Zydus Pharmaceuticals is recalling Erythromycin Tablets, 250 mg, nationwide because certain lots contain N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit due to CGMP deviations.

    Product
    ERYTHROMYCIN — ERYTHROMYCIN (ERYTHROMYCIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0545-2026·2026-05-27

    Erythromycin 500 mg Tablets Recalled for Impurity Above Limits

    Zydus Pharmaceuticals is recalling erythromycin 500 mg tablets nationwide due to the presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit, resulting from manufacturing deviations.

    Product
    ERYTHROMYCIN — ERYTHROMYCIN (ERYTHROMYCIN)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0553-2026·2026-05-27

    MG217 Multi-Symptom Treatment Cream recalled for microbial contamination

    Wisconsin Pharmacal Company is recalling MG217 Multi-Symptom Treatment Cream & Skin Protectant due to confirmed presence of Staphylococcus aureus contamination. Affected units are 6 oz tubes with Lot #1024088, expiring 11/30/2026, distributed nationwide and in the Bahamas.

    Product
    MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0546-2026·2026-05-27

    CIMZIA injection recalled due to lack of sterility assurance

    UCB Biosciences is recalling CIMZIA (certolizumab pegol) prefilled syringes nationwide because of a lack of assurance of sterility. Affected lots are distributed across the US.

    Product
    CIMZIA — CIMZIA (CERTOLIZUMAB PEGOL)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0541-2026·2026-05-27

    Liraglutide Injection Recalled Due to Particulate Matter in Cartridges

    Lupin Pharmaceuticals is recalling Liraglutide Injection due to the presence of white thread-like structures (particulate matter) found in cartridges. The recall affects 217,621 pen injectors distributed nationwide.

    Product
    LIRAGLUTIDE — LIRAGLUTIDE (LIRAGLUTIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0542-2026·2026-05-27

    Gas-X Simethicone 125 mg softgels recall for incomplete labeling

    Haleon is recalling Gas-X Simethicone 125 mg softgels due to incomplete inactive ingredient information on carton labeling.

    Product
    Gas-X, Simethicone 125 mg/ ANTIGAS, 120 SoftGels, Distributed by: Haleon, Warren, NJ 07059, UPC: 3 00674 35041 9.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0534-2026·2026-05-27

    Primidone Tablets Recalled Due to API Cross-Contamination

    Golden State Medical Supply Inc. is recalling Primidone 50 mg tablets due to cross-contamination of the active pharmaceutical ingredient with trace amounts of Acemetacin API. The recall affects 8,526 bottles distributed nationwide.

    Product
    PRIMIDONE — PRIMIDONE (PRIMIDONE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0548-2026·2026-05-27

    Fentanyl Citrate Sterile Injection Recalled for Subpotent Drug Content

    IntegraDose Compounding Services LLC is recalling fentanyl citrate sterile injection (2,500 mcg/50mL) distributed nationwide due to subpotent drug content. The voluntary recall affects 376 cassettes with lot number 20260310FEN-1, expiration date 09/06/2026.

    Product
    fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.
    Category
    Drug
    Distribution
    Distributed nationwide

Looking for a different category? Browse all recalls.